The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group / Sardanelli, F.; Boetes, B.; Decker, T.; Federico, Massimo; Gilbert, F. J.; Helbich, T.; Heywang Kobrunner, S. H.; Kaiser, W. A.; Kerin, M. J.; Mansel, R. E.; Marotti, L.; Martincich, L.; Mauriac, L.; Meijers Heijboer, H.; Orecchia, R.; Panizza, P.; Ponti, A.; Purushotham, A. D.; Regitnig, P.; Rosselli Del Turco, M.; Thibaukt, F.; Wilson, R.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - ELETTRONICO. - 46 (8):(2010), pp. 1296-1316. [10.1016/j.ejca.2010.02.015]

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

FEDERICO, Massimo;
2010

Abstract

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.
2010
46 (8)
1296
1316
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group / Sardanelli, F.; Boetes, B.; Decker, T.; Federico, Massimo; Gilbert, F. J.; Helbich, T.; Heywang Kobrunner, S. H.; Kaiser, W. A.; Kerin, M. J.; Mansel, R. E.; Marotti, L.; Martincich, L.; Mauriac, L.; Meijers Heijboer, H.; Orecchia, R.; Panizza, P.; Ponti, A.; Purushotham, A. D.; Regitnig, P.; Rosselli Del Turco, M.; Thibaukt, F.; Wilson, R.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - ELETTRONICO. - 46 (8):(2010), pp. 1296-1316. [10.1016/j.ejca.2010.02.015]
Sardanelli, F.; Boetes, B.; Decker, T.; Federico, Massimo; Gilbert, F. J.; Helbich, T.; Heywang Kobrunner, S. H.; Kaiser, W. A.; Kerin, M. J.; Mansel, R. E.; Marotti, L.; Martincich, L.; Mauriac, L.; Meijers Heijboer, H.; Orecchia, R.; Panizza, P.; Ponti, A.; Purushotham, A. D.; Regitnig, P.; Rosselli Del Turco, M.; Thibaukt, F.; Wilson, R.
File in questo prodotto:
File Dimensione Formato  
Sardanelli.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 274.96 kB
Formato Adobe PDF
274.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/644694
Citazioni
  • ???jsp.display-item.citation.pmc??? 225
  • Scopus 734
  • ???jsp.display-item.citation.isi??? 652
social impact